3-Hydroxyphencyclidine (3-HPC), a metabolite of phencyclidine (PCP), is ever more attracting clinical scrutiny due to initial data suggesting distinct pharmacological properties. Current studies indicate that 3-HPC may possess distinct effects on the nervous structure, arguably influencing to some of the unexpected manifestations associated with PC